|
Guo, Hong; Barberi, Theresa; Suresh, Rahul et al. (2018) Progression from the Common Lymphoid Progenitor to B/Myeloid PreproB and ProB Precursors during B Lymphopoiesis Requires C/EBP?. J Immunol 201:1692-1704
|
|
Martin, Allison M; Nirschl, Christopher J; Polanczyk, Magda J et al. (2018) PD-L1 expression in medulloblastoma: an evaluation by subgroup. Oncotarget 9:19177-19191
|
|
Barberi, Theresa; Martin, Allison; Suresh, Rahul et al. (2018) Absence of host NF-?B p50 induces murine glioblastoma tumor regression, increases survival, and decreases T-cell induction of tumor-associated macrophage M2 polarization. Cancer Immunol Immunother 67:1491-1503
|
|
Lemberg, Kathryn M; Vornov, James J; Rais, Rana et al. (2018) We're Not ""DON"" Yet: Optimal Dosing and Prodrug Delivery of 6-Diazo-5-oxo-L-norleucine. Mol Cancer Ther 17:1824-1832
|
|
Reed, Damon R; Hayashi, Masanori; Wagner, Lars et al. (2017) Treatment pathway of bone sarcoma in children, adolescents, and young adults. Cancer 123:2206-2218
|
|
Cooper, Stacy; Rubens, Jeffrey; Bodurtha, Joann (2017) Five Pediatric Cancers - Update on Genetic Implications. Curr Pediatr Rev 13:42-48
|
|
Shad, Aziza T; Huo, Jeffrey S; Darcy, Courtney et al. (2017) Tolerance and effectiveness of nivolumab after pediatric T-cell replete, haploidentical, bone marrow transplantation: A case report. Pediatr Blood Cancer 64:
|
|
Nguyen, Bao; Williams, Allen B; Young, David J et al. (2017) FLT3 activating mutations display differential sensitivity to multiple tyrosine kinase inhibitors. Oncotarget 8:10931-10944
|
|
Kim, Jennifer E; Patel, Mira A; Mangraviti, Antonella et al. (2017) Combination Therapy with Anti-PD-1, Anti-TIM-3, and Focal Radiation Results in Regression of Murine Gliomas. Clin Cancer Res 23:124-136
|
|
Miyahara, Hiroaki; Yadavilli, Sridevi; Natsumeda, Manabu et al. (2017) The dual mTOR kinase inhibitor TAK228 inhibits tumorigenicity and enhances radiosensitization in diffuse intrinsic pontine glioma. Cancer Lett 400:110-116
|
Showing the most recent 10 out of 108 publications
